PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy

Y Yoshizawa, Y Kono, K Ogawara, T Kimura… - International journal of …, 2011 - Elsevier
To find out potent paclitaxel (PTX) formulations for cancer chemotherapy, we formulated PTX
in O/W emulsion and liposome selected as candidates of nanocarriers for PTX. Surface …
被引用次数：166 相关文章

[引用][C] PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy

Y Yoshizawa, Y Kono, K Ogawara, T Kimura… - International Journal of …, 2011 - cir.nii.ac.jp
PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 …

PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy

Y Yoshizawa, Y Kono, K Ogawara… - International …, 2011 - pubmed.ncbi.nlm.nih.gov
To find out potent paclitaxel (PTX) formulations for cancer chemotherapy, we formulated PTX
in O/W emulsion and liposome selected as candidates of nanocarriers for PTX. Surface …

PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy

Y Yoshizawa, Y Kono, K Ogawara, T Kimura… - International Journal of …, 2011 - infona.pl
To find out potent paclitaxel (PTX) formulations for cancer chemotherapy, we formulated PTX
in O/W emulsion and liposome selected as candidates of nanocarriers for PTX. Surface …

[引用][C] PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy

Y YOSHIZAWA, Y KONO, KI OGAWARA… - International journal …, 2011 - pascal-francis.inist.fr
PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …

PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy

Y Yoshizawa, Y Kono, K Ogawara… - International …, 2011 - okayama.elsevierpure.com
抄録 To find out potent paclitaxel (PTX) formulations for cancer chemotherapy, we
formulated PTX in O/W emulsion and liposome selected as candidates of nanocarriers for …

PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy.

Y Yoshizawa, Y Kono, K Ogawara… - International Journal of …, 2011 - europepmc.org
To find out potent paclitaxel (PTX) formulations for cancer chemotherapy, we formulated PTX
in O/W emulsion and liposome selected as candidates of nanocarriers for PTX. Surface …

PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy

Y Yoshizawa, Y Kono, K Ogawara… - International …, 2011 - okayama.elsevierpure.com
To find out potent paclitaxel (PTX) formulations for cancer chemotherapy, we formulated PTX
in O/W emulsion and liposome selected as candidates of nanocarriers for PTX. Surface …

[引用][C] PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy

Y YOSHIZAWA, Y KONO, KI OGAWARA… - International journal of …, 2011 - Elsevier